Illinois
Colorectal cancer clinical trials in Illinois
73 colorectal cancer studies are recruiting participants at sites in 70 cities across Illinois as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Illinois city with a recruiting study
Chicago (53), Peoria (14), Springfield (11), Alton (9), Bloomington (9), Carterville (9), Danville (9), Decatur (9), Effingham (9), Galesburg (9), O'Fallon (9), Ottawa (9), Pekin (9), Peru (9), Urbana (9), Washington (9), Canton (8), Mattoon (8), Mount Vernon (8), Aurora (7), Carthage (7), Centralia (7), Dixon (7), Downers Grove (7), Eureka (7), Kewanee (7), Libertyville (7), Macomb (7), Normal (7), Oak Lawn (7), Princeton (7), Arlington Heights (6), Barrington (6), Carbondale (6), Crystal Lake (6), Hazel Crest (6), Park Ridge (6), Elgin (5), Rockford (5), Hinsdale (4), Skokie (4), Evanston (3), New Lenox (3), Zion (3), DeKalb (2), Elmhurst (2), Geneva (2), Harvey (2), Lake Barrington (2), Lisle (2), Maywood (2), Moline (2), Naperville (2), Orland Park (2), Palos Heights (2), Shiloh (2), Warrenville (2), Yorkville (2), Bourbonnais (1), Champaign (1), Evergreen Park (1), Glenview (1), Grayslake (1), Highland Park (1), Hines (1), Lake Forest (1), Morris (1), Niles (1), Oak Park (1), Plainfield (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Recently updated studies in Illinois
Basic details from each study's public record (the 12 most recently updated of 73). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Recruiting in
- Chicago
- Registry record
- NCT05863195 · updated
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Recruiting in
- Skokie
- Registry record
- NCT06324357 · updated
Shield Post-Approval Study Protocol
- Observational
- Ages 45 to 81
- All sexes
- Sponsor
- Guardant Health, Inc.
- Recruiting in
- Bourbonnais · Champaign · Chicago · and 4 more U.S. locations
- Registry record
- NCT06880055 · updated
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Evanston · Lisle
- Registry record
- NCT06997497 · updated
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Recruiting in
- Arlington Heights
- Registry record
- NCT04929223 · updated
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Recruiting in
- Alton · Bloomington · Canton · and 24 more U.S. locations
- Registry record
- NCT07018869 · updated
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
- Observational
- Ages 60 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Recruiting in
- Bloomington · Canton · Carterville · and 16 more U.S. locations
- Registry record
- NCT03998202 · updated
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Summit Therapeutics
- Recruiting in
- Chicago · Elmhurst · O'Fallon
- Registry record
- NCT07228832 · updated
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Oncolytics Biotech
- Recruiting in
- Chicago
- Registry record
- NCT07446322 · updated
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Recruiting in
- Arlington Heights · Peoria · Springfield
- Registry record
- NCT07549412 · updated
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- No phase
- Ages 45 to 70
- All sexes
- Sponsor
- NRG Oncology
- Recruiting in
- Alton · Chicago · Hines · and 4 more U.S. locations
- Registry record
- NCT05080673 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Recruiting in
- Alton · Aurora · Barrington · and 54 more U.S. locations
- Registry record
- NCT05174169 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Illinois on ClinicalTrials.gov.
Ask about studies in Illinois
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections